In November last year, the Biden administration proposed a new rule that would allow drugs like Wegovy and Zepbound to be ...

The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...